title: Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.
abstract: Four decades ago, angiogenesis was recognized as a therapeutic target for blocking cancer growth. Because of its importance, VEGF has been at the center stage of antiangiogenic therapy. Now, several years after FDA approval of an anti-VEGF antibody as the first antiangiogenic agent, many patients with cancer and ocular neovascularization have benefited from VEGF-targeted therapy; however, this anticancer strategy is challenged by insufficient efficacy, intrinsic refractoriness, and resistance. Here, we examine recent discoveries of new mechanisms underlying angiogenesis, discuss successes and challenges of current antiangiogenic therapy, and highlight emerging antiangiogenic paradigms.
authors.affiliation: Vesalius Research Center, University of Leuven, Leuven, Belgium.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Welti
authors.forename: Sonja
authors.initials: S
authors.lastname: Loges
authors.forename: Stefanie
authors.initials: S
authors.lastname: Dimmeler
authors.forename: Peter
authors.initials: P
authors.lastname: Carmeliet
mesh_terms: D020533:Angiogenesis Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D042501:Angiogenic Proteins / Q000502:physiology; D000818:Animals; D049109:Cell Proliferation; D002633:Chemotaxis; D042783:Endothelial Cells / Q000502:physiology; D006801:Humans; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D040321:Vascular Endothelial Growth Factor Receptor-3 / Q000502:physiology
chemical_list: D020533:Angiogenesis Inhibitors; D042501:Angiogenic Proteins; C581309:FLT4 protein, human; D040321:Vascular Endothelial Growth Factor Receptor-3
references.citation: Nature. 2010 Dec 9;468(7325):829-33
references.pmid: 21102433
references.citation: Nature. 2011 Oct 19;478(7369):399-403
references.pmid: 22012397
references.citation: J Clin Invest. 2012 Jun;122(6):1991-2005
references.pmid: 22585576
references.citation: Development. 2011 Nov;138(21):4569-83
references.pmid: 21965610
references.citation: N Engl J Med. 2008 Jul 24;359(4):378-90
references.pmid: 18650514
references.citation: Cancer Cell. 2009 Mar 3;15(3):167-70
references.pmid: 19249675
references.citation: J Pathol. 2012 Aug;227(4):404-16
references.pmid: 22611017
references.citation: Nat Cell Biol. 2010 Oct;12(10):943-53
references.pmid: 20871601
references.citation: J Clin Oncol. 2009 Oct 1;27(28):4733-40
references.pmid: 19720927
references.citation: Nat Rev Cancer. 2007 May;7(5):327-31
references.pmid: 17457300
references.citation: Cancer Res. 2011 Sep 15;71(18):6073-83
references.pmid: 21803743
references.citation: Nature. 2010 Feb 11;463(7282):E6-7
references.pmid: 20147986
references.citation: Lancet Oncol. 2013 May;14(6):552-62
references.pmid: 23598172
references.citation: Dev Cell. 2012 Mar 13;22(3):501-14
references.pmid: 22364862
references.citation: Nat Med. 2010 Jan;16(1):116-22
references.pmid: 20023634
references.citation: Cancer Cell. 2011 Apr 12;19(4):512-26
references.pmid: 21481792
references.citation: N Engl J Med. 2011 Feb 10;364(6):501-13
references.pmid: 21306237
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17069-74
references.pmid: 17942672
references.citation: Cancer Cell. 2009 Mar 3;15(3):232-9
references.pmid: 19249681
references.citation: Cell. 2011 Sep 16;146(6):873-87
references.pmid: 21925313
references.citation: Cell. 2013 Feb 28;152(5):1065-76
references.pmid: 23452854
references.citation: Nat Cell Biol. 2013 Mar;15(3):249-60
references.pmid: 23354168
references.citation: EMBO Rep. 2011 Oct 28;12(11):1135-43
references.pmid: 21979816
references.citation: J Clin Oncol. 2010 Aug 1;28(22):3617-22
references.pmid: 20606091
references.citation: Nat Rev Cancer. 2008 Aug;8(8):579-91
references.pmid: 18596824
references.citation: Cancer Cell. 2013 Feb 11;23(2):171-85
references.pmid: 23375636
references.citation: Nat Rev Drug Discov. 2011 Jun;10(6):417-27
references.pmid: 21629292
references.citation: Cancer Res. 2011 Jul 15;71(14):4758-68
references.pmid: 21613405
references.citation: Curr Biol. 2011 Nov 22;21(22):1942-8
references.pmid: 22079115
references.citation: Cancer Cell. 2010 Dec 14;18(6):630-40
references.pmid: 21130043
references.citation: Nat Neurosci. 2011 Oct 26;14(11):1398-1405
references.pmid: 22030551
references.citation: Development. 2012 Oct;139(20):3859-69
references.pmid: 22951644
references.citation: Cell. 2013 Aug 1;154(3):651-63
references.pmid: 23911327
references.citation: Clin Cancer Res. 2007 Mar 1;13(5):1367-73
references.pmid: 17332278
references.citation: N Engl J Med. 2004 Jun 3;350(23):2335-42
references.pmid: 15175435
references.citation: J Pathol. 2012 Aug;227(4):417-30
references.pmid: 22611036
references.citation: Lancet Oncol. 2010 Jul;11(7):619-26
references.pmid: 20570559
references.citation: J Clin Oncol. 2011 Jan 1;29(1):83-8
references.pmid: 21098326
references.citation: Genes Cancer. 2010 Jan;1(1):12-25
references.pmid: 21779425
references.citation: J Clin Oncol. 2010 Jul 10;28(20):3239-47
references.pmid: 20498403
references.citation: Development. 2011 Oct;138(19):4185-91
references.pmid: 21852397
references.citation: Cancer Cell. 2012 Jul 10;22(1):21-35
references.pmid: 22789536
references.citation: Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11399-404
references.pmid: 12177446
references.citation: Neuron. 2011 Aug 11;71(3):406-24
references.pmid: 21835339
references.citation: Nat Biotechnol. 2007 Aug;25(8):911-20
references.pmid: 17664940
references.citation: Cancer Cell. 2011 Jun 14;19(6):740-53
references.pmid: 21665148
references.citation: Dev Cell. 2012 Mar 13;22(3):489-500
references.pmid: 22421041
references.citation: J Clin Oncol. 2012 Feb 1;30(4):362-71
references.pmid: 22184370
references.citation: Nat Rev Cancer. 2008 Dec;8(12):942-56
references.pmid: 19029957
references.citation: J Clin Oncol. 2012 Jan 10;30(2):134-41
references.pmid: 22025146
references.citation: Cancer Cell. 2010 Aug 9;18(2):171-84
references.pmid: 20708158
references.citation: Curr Oncol Rep. 2007 May;9(3):170-6
references.pmid: 17430687
references.citation: Cancer Lett. 2012 Jul 28;320(2):130-7
references.pmid: 22425960
references.citation: Annu Rev Cell Dev Biol. 2011;27:563-84
references.pmid: 21756109
references.citation: J Clin Invest. 2011 Jun;121(6):2278-89
references.pmid: 21606590
references.citation: Eur J Cancer. 2013 Apr;49(6):1287-96
references.pmid: 23321547
references.citation: Mol Cancer Ther. 2008 Aug;7(8):2272-9
references.pmid: 18687659
references.citation: Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):e107-15
references.pmid: 21940944
references.citation: Nat Cell Biol. 2011 Sep 11;13(10):1202-13
references.pmid: 21909098
references.citation: Genes Dev. 2011 Jul 1;25(13):1399-411
references.pmid: 21724832
references.citation: Dev Cell. 2011 Jan 18;20(1):33-46
references.pmid: 21238923
references.citation: Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6742-7
references.pmid: 19346489
references.citation: Cancer Cell. 2012 Jan 17;21(1):66-81
references.pmid: 22264789
references.citation: Nature. 2011 Oct 09;479(7371):122-6
references.pmid: 21983962
references.citation: Lancet Oncol. 2012 Jul;13(7):724-33
references.pmid: 22608783
references.citation: N Engl J Med. 2007 Dec 27;357(26):2666-76
references.pmid: 18160686
references.citation: Cancer Res. 2011 Jan 1;71(1):19-28
references.pmid: 21199795
references.citation: Nat Rev Clin Oncol. 2012 Apr 24;9(7):378-90
references.pmid: 22525710
references.citation: Ann Oncol. 2010 Sep;21(9):1804-1809
references.pmid: 20150572
references.citation: Nature. 2011 May 19;473(7347):298-307
references.pmid: 21593862
references.citation: J Clin Invest. 2011 Jun;121(6):2157-9
references.pmid: 21606600
references.citation: Cancer Cell. 2009 Mar 3;15(3):220-31
references.pmid: 19249680
references.citation: Nature. 2011 May 12;473(7346):234-8
references.pmid: 21499261
references.citation: Nature. 2010 Dec 9;468(7325):824-8
references.pmid: 21102434
references.citation: Trends Immunol. 2012 Mar;33(3):119-26
references.pmid: 22277903
references.citation: J Biol Chem. 2011 Mar 11;286(10):8055-8066
references.pmid: 21212269
references.citation: N Engl J Med. 2011 Dec 29;365(26):2473-83
references.pmid: 22204724
references.citation: Cancer Res. 2011 Feb 15;71(4):1362-73
references.pmid: 21212415
references.citation: Mol Cancer Ther. 2008 Jan;7(1):71-8
references.pmid: 18187807
references.citation: J Clin Oncol. 2013 Mar 20;31(9):1219-30
references.pmid: 23401453
references.citation: Exp Cell Res. 2013 May 15;319(9):1271-80
references.pmid: 23500414
references.citation: Trends Mol Med. 2011 Jul;17(7):347-62
references.pmid: 21481637
references.citation: Cancer Cell. 2012 Mar 20;21(3):418-29
references.pmid: 22439937
references.citation: N Engl J Med. 2011 Dec 29;365(26):2484-96
references.pmid: 22204725
references.citation: Lancet. 2011 May 28;377(9780):1846-54
references.pmid: 21621716
references.citation: Trends Mol Med. 2013 Jan;19(1):31-9
references.pmid: 23182855
references.citation: N Engl J Med. 2012 Jan 26;366(4):299-309
references.pmid: 22276820
references.citation: Dev Cell. 2009 Sep;17(3):377-86
references.pmid: 19758562
references.citation: Nat Rev Clin Oncol. 2011 Mar 01;8(4):210-21
references.pmid: 21364524
references.citation: Cardiovasc Res. 2011 Jan 1;89(1):204-13
references.pmid: 20733007
references.citation: Nat Neurosci. 2011 Oct 26;14(11):1390-7
references.pmid: 22030550
references.citation: Cancer Cell. 2011 Jan 18;19(1):31-44
references.pmid: 21215706
references.citation: Nat Rev Cancer. 2010 Feb;10(2):138-46
references.pmid: 20094048
references.citation: Nature. 2008 Jul 31;454(7204):656-60
references.pmid: 18594512
references.citation: J Clin Oncol. 2011 Jan 1;29(1):11-6
references.pmid: 20940184
references.citation: N Engl J Med. 2003 Jul 31;349(5):427-34
references.pmid: 12890841
references.citation: Lancet. 2012 May 19;379(9829):1879-86
references.pmid: 22595799
references.citation: Nature. 2010 May 27;465(7297):487-91
references.pmid: 20445540
references.citation: Nature. 2012 Mar 18;484(7392):110-4
references.pmid: 22426001
references.citation: Cancer Cell. 2013 Apr 15;23(4):489-501
references.pmid: 23597563
references.citation: J Clin Oncol. 2012 Oct 1;30(28):3499-506
references.pmid: 22949147
references.citation: J Clin Oncol. 2010 Jan 20;28(3):453-9
references.pmid: 20008624
references.citation: J Clin Oncol. 2012 Oct 10;30(29):3640-7
references.pmid: 22965962
references.citation: Curr Opin Cell Biol. 2012 Apr;24(2):188-93
references.pmid: 22366328
references.citation: J Cell Sci. 2010 Apr 15;123(Pt 8):1235-46
references.pmid: 20233847
references.citation: Cold Spring Harb Perspect Med. 2012 Aug 01;2(8):
references.pmid: 22908198
references.citation: Am J Pathol. 2011 Nov;179(5):2266-77
references.pmid: 21945324
references.citation: Blood. 2011 May 26;117(21):5762-71
references.pmid: 21460247
references.citation: Nature. 2010 May 27;465(7297):483-6
references.pmid: 20445537
references.citation: Cancer Cell. 2012 Jan 17;21(1):82-91
references.pmid: 22264790
references.citation: Development. 2011 May;138(10):2111-20
references.pmid: 21521739
references.citation: Blood. 2011 Mar 3;117(9):2735-44
references.pmid: 21224470
references.citation: Curr Opin Cell Biol. 2010 Oct;22(5):617-25
references.pmid: 20817428
references.citation: Clin Cancer Res. 2012 May 15;18(10):2726-32
references.pmid: 22474319
references.citation: J Clin Invest. 2011 Apr;121(4):1313-28
references.pmid: 21436589
references.citation: J Clin Oncol. 2012 Oct 10;30(29):3588-95
references.pmid: 22965961
references.citation: Blood. 2012 Nov 8;120(19):4104-15
references.pmid: 23007403
references.citation: J Clin Invest. 2006 Oct;116(10):2610-21
references.pmid: 17016557
references.citation: J Clin Oncol. 2012 Jun 10;30(17):2039-45
references.pmid: 22529265
references.citation: Nat Med. 2008 Apr;14(4):448-53
references.pmid: 18345009
references.citation: Dev Cell. 2012 Sep 11;23(3):587-99
references.pmid: 22975327
references.citation: Cancer Cell. 2012 Jan 17;21(1):52-65
references.pmid: 22264788
references.citation: Dev Cell. 2009 Jan;16(1):70-82
references.pmid: 19154719
references.citation: J Clin Oncol. 2008 Nov 20;26(33):5326-34
references.pmid: 18854571
references.citation: Cold Spring Harb Perspect Med. 2012 Mar;2(3):a006486
references.pmid: 22393532
references.citation: Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4274-80
references.pmid: 21262804
references.citation: Blood. 2012 May 10;119(19):4565-76
references.pmid: 22446484
references.citation: J Clin Oncol. 2010 May 1;28(13):2137-43
references.pmid: 20368558
references.citation: Cancer Res. 2013 Mar 15;73(6):1649-57
references.pmid: 23467610
references.citation: Cold Spring Harb Perspect Med. 2012 Oct 01;2(10):
references.pmid: 23028128
references.citation: Blood. 2010 Aug 5;116(5):829-40
references.pmid: 20404134
references.citation: Cell. 2009 Mar 6;136(5):839-851
references.pmid: 19217150
references.citation: Lancet Oncol. 2013 Jan;14(1):29-37
references.pmid: 23168366
references.citation: Cancer Cell. 2013 Apr 15;23(4):477-88
references.pmid: 23597562
references.citation: Clin Cancer Res. 2013 Apr 1;19(7):1773-83
references.pmid: 23307858
references.citation: Nature. 2013 Apr 25;496(7446):445-55
references.pmid: 23619691
references.citation: Blood. 2013 Mar 21;121(12):2352-62
references.pmid: 23315162
references.citation: N Engl J Med. 2007 Jan 11;356(2):125-34
references.pmid: 17215530
references.citation: Adv Cancer Res. 2012;114:21-57
references.pmid: 22588055
references.citation: Curr Opin Hematol. 2011 May;18(3):186-90
references.pmid: 21423011
references.citation: Blood. 2012 Oct 18;120(16):3371-81
references.pmid: 22936663
references.citation: Clin Cancer Res. 2011 Aug 15;17(16):5226-32
references.pmid: 21576085
references.citation: Curr Oncol Rep. 2012 Aug;14(4):285-94
references.pmid: 22544560
references.citation: J Clin Oncol. 2011 Oct 20;29(30):3968-76
references.pmid: 21844504
references.citation: Curr Biol. 2012 Oct 9;22(19):1789-94
references.pmid: 22921365
references.citation: N Engl J Med. 2009 Feb 5;360(6):563-72
references.pmid: 19196673
references.citation: Cancer Treat Rev. 2012 Oct;38(6):673-88
references.pmid: 22365657
references.citation: Circulation. 2010 Oct 26;122(17):1725-33
references.pmid: 20937974
references.citation: J Clin Oncol. 2009 Jul 10;27(20):3312-8
references.pmid: 19451442
references.citation: Nat Med. 2012 Aug;18(8):1208-16
references.pmid: 22797809
references.citation: EMBO Rep. 2011 Oct 28;12(11):1087-8
references.pmid: 22015689
references.citation: Cancer Res. 2013 Jan 1;73(1):108-18
references.pmid: 23149917
references.citation: Genes Dev. 2010 Nov 15;24(22):2480-92
references.pmid: 21078817
references.citation: Cancer Lett. 2013 Jan 1;328(1):18-26
references.pmid: 22922303
references.citation: J Clin Oncol. 2009 Aug 1;27(22):3584-90
references.pmid: 19487381
references.citation: Nature. 2010 Dec 9;468(7325):770-1
references.pmid: 21150987
references.citation: Clin Colorectal Cancer. 2012 Jun;11(2):101-11
references.pmid: 22055112
references.citation: Int J Vasc Med. 2012;2012:293641
references.pmid: 22187650
references.citation: Cancer J. 2010 May-Jun;16(3):202-9
references.pmid: 20526097
references.citation: Cancer Discov. 2012 Mar;2(3):270-87
references.pmid: 22585997